Vir Biotechnology to Participate in the H.C. Wainwright 23rd Annual Global Investment Conference

Rhea-AI Summary

Vir Biotechnology announces that CFO Howard Horn will present at the H.C. Wainwright 23rd Annual Global Investment Conference on September 13, 2021, at 4:00 a.m. PT / 7:00 a.m. ET. The presentation will be available via live webcast on the company's website and archived for 30 days.

Vir focuses on leveraging immunologic insights and technology to combat infectious diseases, with a development pipeline targeting COVID-19, hepatitis B, influenza A, and HIV.

SAN FRANCISCO, Sept. 07, 2021 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that Howard Horn, chief financial officer, is scheduled to present at the H.C. Wainwright 23^rd Annual Global Investment Conference on Monday, Sept. 13, at 4:00 a.m. PT / 7:00 a.m. ET.

A live webcast of the presentation can be accessed under Events & Presentations in the Investors section of the Vir website at www.vir.bio and will be archived there following the presentation for 30 days.

The Company has used, and intends to continue to use, the Investors page of its website as a means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD. Accordingly, investors should monitor the Company’s Investors website, in addition to following the Company’s press releases, Securities and Exchange Commission filings, public conference calls, presentations and webcasts.

About Vir Biotechnology
Vir Biotechnology is a commercial-stage immunology company focused on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. Vir has assembled four technology platforms that are designed to stimulate and enhance the immune system by exploiting critical observations of natural immune processes. Its current development pipeline consists of product candidates targeting COVID-19, hepatitis B virus, influenza A and human immunodeficiency virus. For more information, please visit www.vir.bio.

FAQ

When will Vir Biotechnology present at the H.C. Wainwright Conference?

Vir Biotechnology's CFO Howard Horn will present on September 13, 2021, at 4:00 a.m. PT / 7:00 a.m. ET.

How can I watch Vir Biotechnology's presentation live?

You can access the live webcast of Vir Biotechnology's presentation on their Investors page at www.vir.bio.

What is the focus of Vir Biotechnology?

Vir Biotechnology is focused on treating and preventing serious infectious diseases through innovative immunologic technologies.

What diseases is Vir targeting in its development pipeline?

Vir's development pipeline includes candidates targeting COVID-19, hepatitis B, influenza A, and HIV.

Where can I find more information about Vir Biotechnology?

More information about Vir Biotechnology can be found on their official website at www.vir.bio.